Sucrose, xylitol, and erythritol increase PMMA permeability for depot antibiotics

Clinical Orthopaedics and Related Research

Volumn 461, Issue , 2007, Pages 60-63

  McLaren, Alex C ^a,b   McLaren, Sandra G ^b,c   Hickmon, Miranda K ^b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHRITOL; PHENOLPHTHALEIN; POLY(METHYL METHACRYLATE); SODIUM HYDROXIDE; SUCROSE; XYLITOL; ANTIINFECTIVE AGENT; DRUG CARRIER; MICROSPHERE;

CONFERENCE PAPER; ELUTION; PERMEABILITY; PRIORITY JOURNAL; SOLUBILITY; SPECTROPHOTOMETRY; ARTICLE; COLOR; DELAYED RELEASE FORMULATION; DRUG EFFECT; MATERIALS TESTING;

ANTI-BACTERIAL AGENTS; COLOR; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; ERYTHRITOL; MATERIALS TESTING; MICROSPHERES; PERMEABILITY; PHENOLPHTHALEIN; POLYMETHYL METHACRYLATE; SUCROSE; XYLITOL;

EID: 34548359385     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e3181123e90     Document Type: Conference Paper

References (17)

1. de Cock P, Bechert C. Erythritol: functionality in non caloric functional beverages. Pure Appl Chem. 2002;74:1281-1289.
2. Erythritol. Physical and Chemical Properties page. Eridex™ Web site. Available at: http://www.eridex.com/html/physical.html. Accessed March 7, 2007.
3. Henry SL, Seligson D, Mangino P, Popham GJ. Antibioticimpregnated beads. Part I: bead implantation versus systemic therapy. Orthop Rev. 1991;20:242-247.
4. Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G. Metabolism of erythritol in humans: comparison with glucose and lactitol. Br J Nutr. 1993;69:169-176.
5. Joseph TN, Chen AL, Di Cesare PE. Use of antibiotic-impregnated cement in total joint arthroplasty. J Am Acad Orthop Surg. 2003;11:38-47.
6. Klemm K. The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect. 2001;7:28-31.
7. Kuechle DK, Landon GC, Musher DM, Noble PC. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res. 1991;264:302-308.
8. Levin PD. The effectiveness of various antibiotics in methyl methacrylate. J Bone Joint Surg Br. 1975;57:234-237.
9. McLaren AC, McLaren SG, Smeltzer MS. Xylitol and glycine fillers increase permeability of PMMA to enhance elution of daptomycin. Clin Orthop Relat Res. 2006;451:25-28.
10. McLaren AC, Nelson CL, McLaren SG. DeCLerk GR. The effect of glycine filler on the elution rate of gentamicin from acrylic bone cement: a pilot study. Clin Orthop Relat Res. 2004;427:25-27.
11. McLaren AC, Nelson CL, McLaren SG, Wassell DL. Phenolphthalein used to assess permeability of antibiotic-laden polymethylmethacrylate: a pilot study. Clin Orthop Relat Res. 2005;439:48-51.
12. Nelson CL. The current status of material used for depot delivery of drugs. Clin Orthop Relat Res. 2004;427:72-78.
13. Nelson CL, Griffin FM, Harrison BH, Cooper RE. In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop Relat Res. 1992;284:303-309.
14. Schurman DJ, Trindade C, Hirshman HP, Moser K, Kajiyama G, Stevens P. Antibiotic-acrylic bone cement composites: studies of gentamicin and Palacos. J Bone Joint Surg Am. 1978;60:978-984.
15. Wahlig H, Dingeldein E. Antibiotics and bone cements: experimental and clinical long-term observations. Acta Orthop Scand. 1980;51:49-56.
16. Wahlig H, Dingeldein E, Bergmann R, Reuss K. The release of gentamicin from polymethylmethacrylate beads: an experimental and pharmacokinetic study. J Bone Joint Surg Br. 1978;60:270-275.
17. Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother. 1996;40:2675-2679.